Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?

To: Wisee who wrote (406)	4/16/1998 7:05:00 PM
From: Chuca Marsh	Respond to of 1185

I have a chip on my block over at IZP: RE: <<..Good fortune to us all. Looks like old Jim K was lead into fowl waters by his OLD Captain from what has now come out. Working in a company with a policy of Stonewalling and mis-information with minor distortions might of been contributing to the real reasons that he moved to your company and headed up IR with your holders...>> Jim was IR for a year plus at IZP:VSE Just saying, maybe it wasn't HIS fault but higher up ...over there! Chuca P.S.- I so happen to of received this from T Hoare Junior( My personal Knic Name for Cannacord whom is part of that London Brokerage Group!): <<..MARKET MOVERS (Previous day's closing statistics) Nortran Pharma NRT 486,650 2.15 +.05 June clinical studies in Malaysia for local anaesthetic. Pending large licensing deal. Inflazyme IZP 110,699 .81 +.09 Struggling back into the spotlight with continued development of anti-inflammatory drugs of asthma./...>>